Bioray Biotech Co., Ltd (TPEX:7561)
23.00
-0.60 (-2.54%)
Mar 10, 2026, 11:23 AM CST
Bioray Biotech Revenue
Bioray Biotech had revenue of 114.14M TWD in the half year ending June 30, 2025, with 21.35% growth. This brings the company's revenue in the last twelve months to 230.06M, up 25.32% year-over-year. In the year 2024, Bioray Biotech had annual revenue of 201.71M with 5.15% growth.
Revenue (ttm)
230.06M
Revenue Growth
+25.32%
P/S Ratio
3.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
698.21M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| General Biologicals | 251.38M |
| Prince Pharmaceutical | 798.27M |
| Mediera | 229.85M |
| Original BioMedicals | 381.00K |
| Anxo Pharmaceutical | 883.22M |
| UniPharma | 90.79M |
| Excelsior Biopharma | 898.26M |
| DV Biomed | 712.61M |